Thompson Davis & Co., Inc. Abbott Laboratories Transaction History

Thompson Davis & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $239,442 - $291,984	-2,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $80,871 - $99,022	700 Added 50.0%	2,100 $296,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $6,081 - $7,336	100 Added 7.69%	1,400 $103,000
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $17,271 - $19,062	-300 Reduced 18.75%	1,300 $79,000
Q1 2018 May 02, 2018	BUY	$56.27 - $63.62 $33,762 - $38,172	600 Added 60.0%	1,600 $96,000
Q4 2017 Feb 05, 2018	SELL	$53.68 - $57.47 $42,514 - $45,516	-792 Reduced 44.2%	1,000 $57,000
Q3 2017 Oct 30, 2017	SELL	$48.06 - $53.64 $32,248 - $35,992	-671 Reduced 27.24%	1,792 $96,000
Q2 2017 Aug 10, 2017	BUY	N/A	2,463	2,463 $120,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.